April 11, 2025 - 09:24

CarMax has recently decided to withdraw its previously set financial targets due to ongoing uncertainties surrounding tariffs that have been affecting the automotive industry. CFO Enrique Mayor-Mora emphasized that despite these challenges, the company remains committed to driving sales growth and improving profitability.
The decision to pull back on financial projections reflects a strategic response to the fluctuating economic landscape influenced by trade policies. Tariff-related concerns have created a volatile environment for car manufacturers and retailers alike, leading CarMax to prioritize adaptability in its operations.
Mayor-Mora reassured stakeholders that the company is focusing on its core strengths while navigating these external pressures. By concentrating on enhancing customer experience and optimizing inventory management, CarMax aims to sustain its competitive edge in the market. As the company moves forward, it will continue to monitor the evolving situation and adjust its strategies accordingly to ensure long-term success.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...